In the News

137 News Items found
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024
New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
Physician-scientist Alex Kentsis
In the Lab
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
A researcher working in an MSK lab
New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.
Illustration of Enterococcus
Finding
Lab mice who had lactose removed from their diets had a decreased risk of infection with the Enterococcus bacterium.
Memorial Sloan Kettering medical oncologist Andrea Cercek
In the Clinic
A new treatment is approved for an especially aggressive kind of colorectal cancer.
In this fluorescent microscopy image of endoderm tissue from a mouse embryo, cell membranes are red, cell nuclei are blue, and extra-embryonic endoderm cells are green (they appear turquoise because blue and green are merged).
In the Lab
A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
Rihanna sitting in a chair outside
Feature
Getting to the Root of Pediatric Cancers
MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.
Reicy Bobadilla stands in front of a window with the MSK logo on it
A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.
Scott Lowe
MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.